MedPath

Comparison of extracorporeal shock wave therapy with Intra-Plaque Injection of Verapamil in the Treatment of Peyronie's Disease

Phase 2
Recruiting
Conditions
Peyronie's disease.
N48.6
Induration penis plastica
Registration Number
IRCT20130812014333N169
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
34
Inclusion Criteria

Age between 18 and 65
The duration of the disease is more than 12 months
Diagnosis of pneumonia based on the opinion of a urologist and the presence of palpable plaque
Married patients

Exclusion Criteria

Patient with calcified plaque
History of penile surgery
History of hypo or epispadias
History of intra-plaque injection into the penis
Existence of 2 lesions or lesions with non-measurable shape

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of pain. Timepoint: Beginning of study, end of week 16. Method of measurement: Based on Visual Pain Scale (VAS).;Erectile dysfunction. Timepoint: Beginning of study, end of week 16. Method of measurement: Based on the Erection Function Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath